PSME3IP1
Basic information
Region (hg38): 16:57152466-57186116
Previous symbols: [ "C16orf94", "FAM192A" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PSME3IP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 0 | 0 |
Variants in PSME3IP1
This is a list of pathogenic ClinVar variants found in the PSME3IP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-57154312-T-C | not specified | Uncertain significance (Apr 28, 2022) | ||
16-57154318-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
16-57154405-G-C | not specified | Uncertain significance (Aug 29, 2023) | ||
16-57154467-A-T | not specified | Uncertain significance (Feb 11, 2025) | ||
16-57154468-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
16-57154484-C-T | not specified | Uncertain significance (Nov 08, 2021) | ||
16-57167220-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
16-57172265-G-C | not specified | Uncertain significance (May 15, 2023) | ||
16-57172340-T-A | not specified | Uncertain significance (Jul 14, 2024) | ||
16-57172345-T-A | not specified | Uncertain significance (Jun 12, 2023) | ||
16-57172346-C-T | not specified | Uncertain significance (May 15, 2024) | ||
16-57172367-T-C | not specified | Uncertain significance (Jun 05, 2024) | ||
16-57172794-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
16-57173785-G-A | not specified | Uncertain significance (Jan 27, 2025) | ||
16-57173836-C-T | not specified | Uncertain significance (Sep 27, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PSME3IP1 | protein_coding | protein_coding | ENST00000309137 | 6 | 33651 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.195 | 0.803 | 124786 | 0 | 8 | 124794 | 0.0000321 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.31 | 95 | 138 | 0.686 | 0.00000731 | 1669 |
Missense in Polyphen | 26 | 44.181 | 0.58848 | 567 | ||
Synonymous | 0.511 | 50 | 54.8 | 0.912 | 0.00000309 | 471 |
Loss of Function | 2.69 | 4 | 15.4 | 0.260 | 9.49e-7 | 168 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000928 | 0.0000928 |
European (Non-Finnish) | 0.0000530 | 0.0000530 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Promotes the association of the proteasome activator complex subunit PSME3 with the 20S proteasome and regulates its activity. Inhibits PSME3-mediated degradation of some proteasome substrates, probably by affecting their diffusion rate into the catalytic chamber of the proteasome. Also inhibits the interaction of PSME3 with COIL, inhibits accumulation of PSME3 in Cajal bodies and positively regulates the number of Cajal bodies in the nucleus. {ECO:0000269|PubMed:29934401}.;
Intolerance Scores
- loftool
- 0.196
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 56.64
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.595
- ghis
- 0.517
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.231
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fam192a
- Phenotype
Gene ontology
- Biological process
- negative regulation of protein binding;negative regulation of proteasomal protein catabolic process
- Cellular component
- nucleus
- Molecular function
- protein binding